Advice
Following a full submission
pioglitazone (Actos®) is accepted for use within NHS Scotland in combination with insulin in type 2 diabetes mellitus patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance.
It improved glycaemic control when added to insulin in the relevant patient population.
Download detailed advice96KB (PDF)
Medicine details
- Medicine name:
- pioglitazone 15mg, 30mg and 45mg tablets (Actos)
- SMC ID:
- 399/07
- Indication:
- in combination with insulin in type 2 diabetes mellitus patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance
- Pharmaceutical company
- Takeda UK Ltd
- BNF chapter
- Endocrine system
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 10 September 2007